pI: 7.936 |
Length (AA): 1159 |
MW (Da): 132022 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
10 | 199 | 4tql (A) | 47 | 238 | 12.00 | 0.042 | 0.11 | 0.330934 | -1.14 |
200 | 888 | 1gl9 (C) | 372 | 1044 | 20.00 | 0 | 1 | 0.626078 | 1.04 |
315 | 917 | 5gvc (A) | 1 | 612 | 61.00 | 0 | 1 | 1.26888 | -0.8 |
319 | 963 | 2gai (A) | 8 | 599 | 24.00 | 0 | 1 | 0.621114 | 0.71 |
802 | 965 | 3rg9 (A) | 30 | 207 | 28.00 | 0.35 | 0.49 | 0.198101 | 0.61 |
897 | 1055 | 3u7u (A) | 128 | 336 | 31.00 | 0.46 | 0.06 | -0.125213 | 2.07 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129147)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G32000 | DNA topoisomerase, type IA, core |
Babesia bovis | BBOV_II000360 | DNA topoisomerase, putative |
Brugia malayi | Bm1_24915 | DNA topoisomerase III beta-1 |
Caenorhabditis elegans | CELE_Y48C3A.14 | Protein Y48C3A.14, isoform D |
Cryptosporidium hominis | Chro.60278 | DNA topoisomerase III beta-1 |
Cryptosporidium parvum | cgd6_2390 | DNA topoisomerase III beta-1, putative |
Drosophila melanogaster | Dmel_CG3458 | Topoisomerase 3beta |
Echinococcus granulosus | EgrG_000718300 | DNA topoisomerase 3 beta 1 |
Entamoeba histolytica | EHI_042880 | DNA topoisomerase III, putative |
Echinococcus multilocularis | EmuJ_000718300 | DNA topoisomerase 3 beta 1 |
Giardia lamblia | GL50803_15190 | DNA topoisomerase III |
Homo sapiens | ENSG00000100038 | topoisomerase (DNA) III beta |
Leishmania braziliensis | LbrM.28.1950 | DNA topoisomerase III, putative |
Leishmania donovani | LdBPK_281900.1 | DNA topoisomerase III, putative |
Leishmania infantum | LinJ.28.1900 | DNA topoisomerase III, putative |
Leishmania major | LmjF.28.1780 | DNA topoisomerase III, putative |
Leishmania mexicana | LmxM.28.1780 | DNA topoisomerase III, putative |
Loa Loa (eye worm) | LOAG_06591 | DNA topoisomerase III beta-1 |
Mus musculus | ENSMUSG00000022779 | topoisomerase (DNA) III beta |
Neospora caninum | NCLIV_040590 | DNA topoisomerase (EC 5.99.1.2), related |
Oryza sativa | 4347482 | Os09g0500600 |
Onchocerca volvulus | OVOC10269 |
|
Schistosoma japonicum | Sjp_0097620 | expressed protein |
Schistosoma japonicum | Sjp_0045500 | ko:K03165 DNA topoisomerase III, putative |
Schistosoma mansoni | Smp_169790 | prokaryotic DNA topoisomerase |
Schmidtea mediterranea | mk4.000116.05 | DNA topoisomerase 3-beta-1 |
Schmidtea mediterranea | mk4.000116.04 | |
Trypanosoma brucei gambiense | Tbg972.11.10250 | DNA topoisomerase III, putative |
Trypanosoma brucei | Tb927.11.9170 | DNA topoisomerase III, putative |
Trypanosoma congolense | TcIL3000.11.9530 | DNA topoisomerase III, putative |
Trypanosoma cruzi | TcCLB.510901.100 | DNA topoisomerase III, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.0910 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0910 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0910 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.0910 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Bacillus subtilis (strain 168) | DNA topoisomerase III | Compounds | References |